[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$favl06rldekWOFbzWiuMAcf2CJcU8iu4Dj5H7XdgWlfo":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":32,"phaseBuckets":53,"rows":60},"Isfahan University of Medical Sciences",[4],148,false,8,40,28841,5,78,[14,17,19,21,24,26,28,30],{"name":15,"count":16},"Tangier Disease",3,{"name":18,"count":16},"Local Anesthesia",{"name":20,"count":16},"Multiple Sclerosis",{"name":22,"count":23},"Diagnostic Esophagogastroduodenoscopy",2,{"name":25,"count":23},"Contrast-Induced Nephropathy",{"name":27,"count":23},"Distal Radius Fracture",{"name":29,"count":23},"Nutritional and Metabolic Disease",{"name":31,"count":23},"Fatigue",[33,38,43,48],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT06642363","The Effectiveness of Astaxanthin Supplementation on the Clinical Symptoms and Cardio-metabolic Profile in Women with Polycystic Ovary Syndrome","2025-07-22","Subjects in the intervention group will receive one capsule containing 10 mg Astaper day made by the \"Zyest Technology Tarawat Zendig\" institute in Iran. The dosage of ASX is determined based on the s",{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT06595355","Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin","2025-09-22","bevacizumab with oral curcumin",{"nctId":44,"briefTitle":45,"date":46,"intervention":47},"NCT07230223","Effect of Ev.FV on Wound Healing in Dystrophic Epidermolysis Bullosa","2025-12-01","Ev.FV 1.0 x 1011 par\u002Fml",{"nctId":49,"briefTitle":50,"date":51,"intervention":52},"NCT06466850","Mesenchymal Stem Cells Derived Exosomes in Osteoarthritis Patients","2026-12-25","Exosome",[54,55,56,57,58,59],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[61,88,106,128,150,182,237,259,285,303,328,354,380,405,441,477,513,552,570,588,606,633,651,676,694,721,739,757,775,793,811,835,863,881,899,917,941,967,985,1009,1034,1060,1085,1103,1126,1144,1168,1186,1210,1228,1255,1273,1291,1318,1346,1364,1382,1400,1418,1440,1471,1509,1527,1556,1574,1598,1621,1639,1663,1686,1709,1727,1755,1773,1796,1814,1840,1858,1882,1906,1933,1959,1977,2000,2025,2043,2069,2087,2113,2134,2157,2175,2201,2219,2253,2292,2317,2335,2358,2376,2394,2412],{"intervention":42,"totalTrials":62,"cells":63},1,{"EARLY_PHASE1":64,"PHASE1":67,"PHASE2":69,"PHASE3":71,"PHASE4":84,"NA":86},{"trials":65,"activeCount":66},[],0,{"trials":68,"activeCount":66},[],{"trials":70,"activeCount":66},[],{"trials":72,"activeCount":62,"soonestReadout":41},[73],{"nctId":39,"briefTitle":40,"status":74,"phases":75,"primaryCompletion":41,"completion":41,"start":76,"enrollment":77,"conditions":78,"interventions":82},"RECRUITING",[56,57],"2021-10-10",52,[79,80,81],"Diabetic Macular Edema","Macular Edema","Retinal Neovascularization",[42,83],"bevacizumab with oral placebo",{"trials":85,"activeCount":66},[],{"trials":87,"activeCount":66},[],{"intervention":83,"totalTrials":62,"cells":89},{"EARLY_PHASE1":90,"PHASE1":92,"PHASE2":94,"PHASE3":96,"PHASE4":102,"NA":104},{"trials":91,"activeCount":66},[],{"trials":93,"activeCount":66},[],{"trials":95,"activeCount":66},[],{"trials":97,"activeCount":62,"soonestReadout":41},[98],{"nctId":39,"briefTitle":40,"status":74,"phases":99,"primaryCompletion":41,"completion":41,"start":76,"enrollment":77,"conditions":100,"interventions":101},[56,57],[79,80,81],[42,83],{"trials":103,"activeCount":66},[],{"trials":105,"activeCount":66},[],{"intervention":47,"totalTrials":62,"cells":107},{"EARLY_PHASE1":108,"PHASE1":110,"PHASE2":112,"PHASE3":122,"PHASE4":124,"NA":126},{"trials":109,"activeCount":66},[],{"trials":111,"activeCount":66},[],{"trials":113,"activeCount":62,"soonestReadout":46},[114],{"nctId":44,"briefTitle":45,"status":74,"phases":115,"primaryCompletion":46,"completion":51,"start":116,"enrollment":117,"conditions":118,"interventions":121},[55,56],"2024-01-09",20,[119,120],"Dystrophic Epidermolysis Bullosa","Wound Heal",[47],{"trials":123,"activeCount":66},[],{"trials":125,"activeCount":66},[],{"trials":127,"activeCount":66},[],{"intervention":37,"totalTrials":62,"cells":129},{"EARLY_PHASE1":130,"PHASE1":132,"PHASE2":142,"PHASE3":144,"PHASE4":146,"NA":148},{"trials":131,"activeCount":66},[],{"trials":133,"activeCount":62,"soonestReadout":36},[134],{"nctId":34,"briefTitle":35,"status":74,"phases":135,"primaryCompletion":36,"completion":36,"start":136,"enrollment":137,"conditions":138,"interventions":141},[55],"2024-07-22",44,[139,140],"PCO - Polycystic Ovaries","Obesity and Obesity-related Medical Conditions",[37],{"trials":143,"activeCount":66},[],{"trials":145,"activeCount":66},[],{"trials":147,"activeCount":66},[],{"trials":149,"activeCount":66},[],{"intervention":52,"totalTrials":23,"cells":151},{"EARLY_PHASE1":152,"PHASE1":154,"PHASE2":156,"PHASE3":170,"PHASE4":172,"NA":174},{"trials":153,"activeCount":66},[],{"trials":155,"activeCount":66},[],{"trials":157,"activeCount":66},[158],{"nctId":159,"briefTitle":160,"status":161,"phases":162,"primaryCompletion":163,"completion":164,"start":165,"enrollment":11,"conditions":166,"interventions":168},"NCT03384433","Allogenic Mesenchymal Stem Cell Derived Exosome in Patients With Acute Ischemic Stroke","UNKNOWN",[55,56],"2021-06-17","2021-12-17","2019-04-17",[167],"Cerebrovascular Disorders",[169],"exosome",{"trials":171,"activeCount":66},[],{"trials":173,"activeCount":66},[],{"trials":175,"activeCount":62,"soonestReadout":51},[176],{"nctId":49,"briefTitle":50,"status":74,"phases":177,"primaryCompletion":51,"completion":51,"start":178,"enrollment":117,"conditions":179,"interventions":181},[59],"2024-01-01",[180],"Osteoarthritis, Knee",[52],{"intervention":183,"totalTrials":16,"cells":184},"Fentanyl",{"EARLY_PHASE1":185,"PHASE1":187,"PHASE2":189,"PHASE3":191,"PHASE4":221,"NA":235},{"trials":186,"activeCount":66},[],{"trials":188,"activeCount":66},[],{"trials":190,"activeCount":66},[],{"trials":192,"activeCount":66},[193,207],{"nctId":194,"briefTitle":195,"status":196,"phases":197,"primaryCompletion":198,"completion":199,"start":200,"enrollment":201,"conditions":202,"interventions":205},"NCT04414800","Intranasal Ketamine Versus Intranasal Fentanyl","COMPLETED",[57],"2018-03-20","2018-04-15","2017-04-01",125,[203,204],"Multiple Trauma","Pain, Acute",[206,183],"Ketamine",{"nctId":208,"briefTitle":209,"status":196,"phases":210,"primaryCompletion":211,"completion":211,"start":212,"enrollment":213,"conditions":214,"interventions":216},"NCT02752308","Effectiveness of Caudal Epidural Block on Intraoperative Blood Loss During Hypospadias Repair",[56,57],"2015-03","2014-09",60,[215],"Hypospadias",[217,218,183,219,220],"Bupivacaine","Dilute epinephrine","dextrose plus sodium chloride.","neostigmine and atropine",{"trials":222,"activeCount":66},[223],{"nctId":224,"briefTitle":225,"status":196,"phases":226,"primaryCompletion":227,"completion":228,"start":229,"enrollment":230,"conditions":231,"interventions":233},"NCT01843296","Effects of Addition of Magnesium Sulfate in Spinal Anesthesia on Sensory-Motor Blocks and Postoperative Pain in Lumbar Disk Herniation Surgery",[58],"2012-12","2013-04","2012-11",105,[232],"Lumbar Spine Disc Herniation",[234,217,183],"Magnesium Sulfate",{"trials":236,"activeCount":66},[],{"intervention":217,"totalTrials":23,"cells":238},{"EARLY_PHASE1":239,"PHASE1":241,"PHASE2":243,"PHASE3":245,"PHASE4":251,"NA":257},{"trials":240,"activeCount":66},[],{"trials":242,"activeCount":66},[],{"trials":244,"activeCount":66},[],{"trials":246,"activeCount":66},[247],{"nctId":208,"briefTitle":209,"status":196,"phases":248,"primaryCompletion":211,"completion":211,"start":212,"enrollment":213,"conditions":249,"interventions":250},[56,57],[215],[217,218,183,219,220],{"trials":252,"activeCount":66},[253],{"nctId":224,"briefTitle":225,"status":196,"phases":254,"primaryCompletion":227,"completion":228,"start":229,"enrollment":230,"conditions":255,"interventions":256},[58],[232],[234,217,183],{"trials":258,"activeCount":66},[],{"intervention":260,"totalTrials":62,"cells":261},"Empagliflozin 25 MG",{"EARLY_PHASE1":262,"PHASE1":264,"PHASE2":266,"PHASE3":268,"PHASE4":270,"NA":283},{"trials":263,"activeCount":66},[],{"trials":265,"activeCount":66},[],{"trials":267,"activeCount":66},[],{"trials":269,"activeCount":66},[],{"trials":271,"activeCount":66},[272],{"nctId":273,"briefTitle":274,"status":196,"phases":275,"primaryCompletion":276,"completion":277,"start":278,"enrollment":279,"conditions":280,"interventions":282},"NCT04143321","Antiischemic Effects of Empagliflozin in Diabetic Patients With Refractory Angina",[58],"2019-04-15","2019-05-23","2018-09-10",75,[281],"Diabetes Mellitus",[260],{"trials":284,"activeCount":66},[],{"intervention":234,"totalTrials":62,"cells":286},{"EARLY_PHASE1":287,"PHASE1":289,"PHASE2":291,"PHASE3":293,"PHASE4":295,"NA":301},{"trials":288,"activeCount":66},[],{"trials":290,"activeCount":66},[],{"trials":292,"activeCount":66},[],{"trials":294,"activeCount":66},[],{"trials":296,"activeCount":66},[297],{"nctId":224,"briefTitle":225,"status":196,"phases":298,"primaryCompletion":227,"completion":228,"start":229,"enrollment":230,"conditions":299,"interventions":300},[58],[232],[234,217,183],{"trials":302,"activeCount":66},[],{"intervention":304,"totalTrials":62,"cells":305},"Alprazolam",{"EARLY_PHASE1":306,"PHASE1":308,"PHASE2":310,"PHASE3":312,"PHASE4":314,"NA":326},{"trials":307,"activeCount":66},[],{"trials":309,"activeCount":66},[],{"trials":311,"activeCount":66},[],{"trials":313,"activeCount":66},[],{"trials":315,"activeCount":66},[316],{"nctId":317,"briefTitle":318,"status":196,"phases":319,"primaryCompletion":320,"completion":321,"start":322,"enrollment":213,"conditions":323,"interventions":325},"NCT01546090","Effect of Alprazolam on the Success of Inferior Alveolar Nerve (IAN) Block",[58],"2011-10","2012-02","2011-03",[324],"Inferior Alveolar Nerve Block Failure",[304],{"trials":327,"activeCount":66},[],{"intervention":329,"totalTrials":62,"cells":330},"Dexamethasone applied on pulp or Dexamethasone did not applied on pulp",{"EARLY_PHASE1":331,"PHASE1":333,"PHASE2":335,"PHASE3":337,"PHASE4":339,"NA":352},{"trials":332,"activeCount":66},[],{"trials":334,"activeCount":66},[],{"trials":336,"activeCount":66},[],{"trials":338,"activeCount":66},[],{"trials":340,"activeCount":66},[341],{"nctId":342,"briefTitle":343,"status":196,"phases":344,"primaryCompletion":345,"completion":346,"start":347,"enrollment":348,"conditions":349,"interventions":351},"NCT02574468","Effect of Topical Dexamethasone on Histologic Response of Human Dental Pulp",[58],"2013-06","2013-12","2013-01",10,[350],"Vital Pulp Therapy",[329],{"trials":353,"activeCount":66},[],{"intervention":355,"totalTrials":62,"cells":356},"lidocaine",{"EARLY_PHASE1":357,"PHASE1":359,"PHASE2":361,"PHASE3":363,"PHASE4":365,"NA":378},{"trials":358,"activeCount":66},[],{"trials":360,"activeCount":66},[],{"trials":362,"activeCount":66},[],{"trials":364,"activeCount":66},[],{"trials":366,"activeCount":66},[367],{"nctId":368,"briefTitle":369,"status":161,"phases":370,"primaryCompletion":371,"completion":372,"start":373,"enrollment":374,"conditions":375,"interventions":377},"NCT01417572","Adjunctive Local Application of Lidocaine During Scleral Buckling Under General Anesthesia",[58],"2010-08","2011-09","2010-01",30,[376],"Retinal Detachment",[355],{"trials":379,"activeCount":66},[],{"intervention":381,"totalTrials":62,"cells":382},"Buspirone",{"EARLY_PHASE1":383,"PHASE1":385,"PHASE2":387,"PHASE3":389,"PHASE4":391,"NA":403},{"trials":384,"activeCount":66},[],{"trials":386,"activeCount":66},[],{"trials":388,"activeCount":66},[],{"trials":390,"activeCount":66},[],{"trials":392,"activeCount":66},[393],{"nctId":394,"briefTitle":395,"status":196,"phases":396,"primaryCompletion":397,"completion":200,"start":398,"enrollment":399,"conditions":400,"interventions":402},"NCT03444831","Buspirone Plus Omeprazole for Functional Dyspepsia",[58],"2017-03-01","2016-03-01",70,[401],"Dyspepsia",[381],{"trials":404,"activeCount":66},[],{"intervention":406,"totalTrials":23,"cells":407},"Sublingual alprazolam",{"EARLY_PHASE1":408,"PHASE1":410,"PHASE2":412,"PHASE3":414,"PHASE4":437,"NA":439},{"trials":409,"activeCount":66},[],{"trials":411,"activeCount":66},[],{"trials":413,"activeCount":66},[],{"trials":415,"activeCount":66},[416,427],{"nctId":417,"briefTitle":418,"status":196,"phases":419,"primaryCompletion":420,"completion":347,"start":372,"enrollment":421,"conditions":422,"interventions":423},"NCT01949038","Alprazolam as Conscious Sedation for Upper Gastrointestinal Endoscopy",[56,57],"2012-10",220,[22],[424,406,425,426],"Oral alprazolam","Oral placebo","Sublingual placebo",{"nctId":428,"briefTitle":429,"status":196,"phases":430,"primaryCompletion":431,"completion":431,"start":432,"enrollment":433,"conditions":434,"interventions":435},"NCT03130842","Premedication With Alprazolam and Midazolam for Upper Gastrointestinal Endoscopy",[56,57],"2017-02-15","2016-09-17",136,[22],[406,436],"Oral midazolam",{"trials":438,"activeCount":66},[],{"trials":440,"activeCount":66},[],{"intervention":442,"totalTrials":23,"cells":443},"0.9% sodium chloride",{"EARLY_PHASE1":444,"PHASE1":446,"PHASE2":448,"PHASE3":450,"PHASE4":473,"NA":475},{"trials":445,"activeCount":66},[],{"trials":447,"activeCount":66},[],{"trials":449,"activeCount":66},[],{"trials":451,"activeCount":66},[452,462],{"nctId":453,"briefTitle":454,"status":196,"phases":455,"primaryCompletion":456,"completion":456,"start":457,"enrollment":458,"conditions":459,"interventions":460},"NCT02114346","High Dose Atorvastatin for Preventing Contrast-induced Nephropathy",[56,57],"2014-02","2013-07",250,[25],[461,442],"Atorvastatin",{"nctId":463,"briefTitle":464,"status":161,"phases":465,"primaryCompletion":466,"start":467,"enrollment":468,"conditions":469,"interventions":470},"NCT02088502","Theophylline, N-acetylcysteine, and Theophylline Plus N-acetylcysteine in Preventing Contrast-induced Nephropathy",[56,57],"2014-04","2013-09",96,[25],[471,472,442],"N-acetylcysteine","Theophylline",{"trials":474,"activeCount":66},[],{"trials":476,"activeCount":66},[],{"intervention":478,"totalTrials":23,"cells":479},"Silymarin",{"EARLY_PHASE1":480,"PHASE1":482,"PHASE2":484,"PHASE3":496,"PHASE4":509,"NA":511},{"trials":481,"activeCount":66},[],{"trials":483,"activeCount":66},[],{"trials":485,"activeCount":66},[486],{"nctId":487,"briefTitle":488,"status":196,"phases":489,"primaryCompletion":490,"completion":490,"start":491,"enrollment":492,"conditions":493,"interventions":495},"NCT01292161","Effects of Silybum Marianum on Treatment of Patients With Chronic Hepatitis C",[56],"2006-09","2006-03",55,[494],"Hepatitis C",[478],{"trials":497,"activeCount":66},[498],{"nctId":499,"briefTitle":500,"status":161,"phases":501,"primaryCompletion":502,"start":503,"enrollment":504,"conditions":505,"interventions":508},"NCT00999349","Therapeutic Effects of Silymarin in Patients With B-thalassemia Major",[56,57],"2009-12","2009-03",140,[506,507],"Beta-thalassemia Major","Iron Overload",[478],{"trials":510,"activeCount":66},[],{"trials":512,"activeCount":66},[],{"intervention":514,"totalTrials":23,"cells":515},"Rituximab",{"EARLY_PHASE1":516,"PHASE1":518,"PHASE2":520,"PHASE3":522,"PHASE4":548,"NA":550},{"trials":517,"activeCount":66},[],{"trials":519,"activeCount":66},[],{"trials":521,"activeCount":66},[],{"trials":523,"activeCount":66},[524,536],{"nctId":525,"briefTitle":526,"status":196,"phases":527,"primaryCompletion":528,"completion":529,"start":530,"enrollment":531,"conditions":532,"interventions":534},"NCT03315923","Comparison of Clinical Effects of Rituximab and Glatiramer Acetate in Secondary Progressive Multiple Sclerosis Patients",[56,57],"2019-02-01","2019-03-01","2017-12-01",84,[533],"Secondary Progressive Multiple Sclerosis",[514,535],"Glatiramer Acetate",{"nctId":537,"briefTitle":538,"status":196,"phases":539,"primaryCompletion":540,"completion":541,"start":542,"enrollment":543,"conditions":544,"interventions":546},"NCT03002038","Comparison of Clinical Effects of Azathioprine and Rituximab NMO-SD Patients",[56,57],"2016-11","2016-12","2015-09",86,[545],"Neuromyelitis Optica Spectrum Disorder",[547,514],"Azathioprine",{"trials":549,"activeCount":66},[],{"trials":551,"activeCount":66},[],{"intervention":424,"totalTrials":62,"cells":553},{"EARLY_PHASE1":554,"PHASE1":556,"PHASE2":558,"PHASE3":560,"PHASE4":566,"NA":568},{"trials":555,"activeCount":66},[],{"trials":557,"activeCount":66},[],{"trials":559,"activeCount":66},[],{"trials":561,"activeCount":66},[562],{"nctId":417,"briefTitle":418,"status":196,"phases":563,"primaryCompletion":420,"completion":347,"start":372,"enrollment":421,"conditions":564,"interventions":565},[56,57],[22],[424,406,425,426],{"trials":567,"activeCount":66},[],{"trials":569,"activeCount":66},[],{"intervention":425,"totalTrials":62,"cells":571},{"EARLY_PHASE1":572,"PHASE1":574,"PHASE2":576,"PHASE3":578,"PHASE4":584,"NA":586},{"trials":573,"activeCount":66},[],{"trials":575,"activeCount":66},[],{"trials":577,"activeCount":66},[],{"trials":579,"activeCount":66},[580],{"nctId":417,"briefTitle":418,"status":196,"phases":581,"primaryCompletion":420,"completion":347,"start":372,"enrollment":421,"conditions":582,"interventions":583},[56,57],[22],[424,406,425,426],{"trials":585,"activeCount":66},[],{"trials":587,"activeCount":66},[],{"intervention":426,"totalTrials":62,"cells":589},{"EARLY_PHASE1":590,"PHASE1":592,"PHASE2":594,"PHASE3":596,"PHASE4":602,"NA":604},{"trials":591,"activeCount":66},[],{"trials":593,"activeCount":66},[],{"trials":595,"activeCount":66},[],{"trials":597,"activeCount":66},[598],{"nctId":417,"briefTitle":418,"status":196,"phases":599,"primaryCompletion":420,"completion":347,"start":372,"enrollment":421,"conditions":600,"interventions":601},[56,57],[22],[424,406,425,426],{"trials":603,"activeCount":66},[],{"trials":605,"activeCount":66},[],{"intervention":607,"totalTrials":62,"cells":608},"High dose Dexamethasone pulses",{"EARLY_PHASE1":609,"PHASE1":611,"PHASE2":613,"PHASE3":615,"PHASE4":629,"NA":631},{"trials":610,"activeCount":66},[],{"trials":612,"activeCount":66},[],{"trials":614,"activeCount":66},[],{"trials":616,"activeCount":66},[617],{"nctId":618,"briefTitle":619,"status":196,"phases":620,"primaryCompletion":621,"completion":621,"start":622,"enrollment":623,"conditions":624,"interventions":627},"NCT02914054","Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With Dexamethasone",[56,57],"2017-09-15","2016-10-01",36,[625,626],"ITP","Croticosteroid Therapy",[607,628],"Prednisone",{"trials":630,"activeCount":66},[],{"trials":632,"activeCount":66},[],{"intervention":628,"totalTrials":62,"cells":634},{"EARLY_PHASE1":635,"PHASE1":637,"PHASE2":639,"PHASE3":641,"PHASE4":647,"NA":649},{"trials":636,"activeCount":66},[],{"trials":638,"activeCount":66},[],{"trials":640,"activeCount":66},[],{"trials":642,"activeCount":66},[643],{"nctId":618,"briefTitle":619,"status":196,"phases":644,"primaryCompletion":621,"completion":621,"start":622,"enrollment":623,"conditions":645,"interventions":646},[56,57],[625,626],[607,628],{"trials":648,"activeCount":66},[],{"trials":650,"activeCount":66},[],{"intervention":652,"totalTrials":62,"cells":653},"Ketamine-midazolam",{"EARLY_PHASE1":654,"PHASE1":656,"PHASE2":658,"PHASE3":660,"PHASE4":672,"NA":674},{"trials":655,"activeCount":66},[],{"trials":657,"activeCount":66},[],{"trials":659,"activeCount":66},[],{"trials":661,"activeCount":66},[662],{"nctId":663,"briefTitle":664,"status":196,"phases":665,"primaryCompletion":347,"completion":666,"start":227,"enrollment":667,"conditions":668,"interventions":670},"NCT01807429","Is Analgesic Effect of Low Dose Ketamine-midazolam the Same as Morphine",[56,57],"2013-02",236,[669],"Closed Multiple Fractures of Upper and Lower Limbs",[652,671],"Morphine",{"trials":673,"activeCount":66},[],{"trials":675,"activeCount":66},[],{"intervention":671,"totalTrials":62,"cells":677},{"EARLY_PHASE1":678,"PHASE1":680,"PHASE2":682,"PHASE3":684,"PHASE4":690,"NA":692},{"trials":679,"activeCount":66},[],{"trials":681,"activeCount":66},[],{"trials":683,"activeCount":66},[],{"trials":685,"activeCount":66},[686],{"nctId":663,"briefTitle":664,"status":196,"phases":687,"primaryCompletion":347,"completion":666,"start":227,"enrollment":667,"conditions":688,"interventions":689},[56,57],[669],[652,671],{"trials":691,"activeCount":66},[],{"trials":693,"activeCount":66},[],{"intervention":695,"totalTrials":62,"cells":696},"2% morphine solution",{"EARLY_PHASE1":697,"PHASE1":699,"PHASE2":701,"PHASE3":703,"PHASE4":717,"NA":719},{"trials":698,"activeCount":66},[],{"trials":700,"activeCount":66},[],{"trials":702,"activeCount":66},[],{"trials":704,"activeCount":66},[705],{"nctId":706,"briefTitle":707,"status":196,"phases":708,"primaryCompletion":709,"completion":420,"start":710,"enrollment":374,"conditions":711,"interventions":713},"NCT01837446","Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer",[56,57],"2012-07","2011-07",[712],"Stomatitis",[695,714,715,716],"Magnesium aluminum hydroxide","2% viscous lidocaine","Diphenhydramine",{"trials":718,"activeCount":66},[],{"trials":720,"activeCount":66},[],{"intervention":714,"totalTrials":62,"cells":722},{"EARLY_PHASE1":723,"PHASE1":725,"PHASE2":727,"PHASE3":729,"PHASE4":735,"NA":737},{"trials":724,"activeCount":66},[],{"trials":726,"activeCount":66},[],{"trials":728,"activeCount":66},[],{"trials":730,"activeCount":66},[731],{"nctId":706,"briefTitle":707,"status":196,"phases":732,"primaryCompletion":709,"completion":420,"start":710,"enrollment":374,"conditions":733,"interventions":734},[56,57],[712],[695,714,715,716],{"trials":736,"activeCount":66},[],{"trials":738,"activeCount":66},[],{"intervention":715,"totalTrials":62,"cells":740},{"EARLY_PHASE1":741,"PHASE1":743,"PHASE2":745,"PHASE3":747,"PHASE4":753,"NA":755},{"trials":742,"activeCount":66},[],{"trials":744,"activeCount":66},[],{"trials":746,"activeCount":66},[],{"trials":748,"activeCount":66},[749],{"nctId":706,"briefTitle":707,"status":196,"phases":750,"primaryCompletion":709,"completion":420,"start":710,"enrollment":374,"conditions":751,"interventions":752},[56,57],[712],[695,714,715,716],{"trials":754,"activeCount":66},[],{"trials":756,"activeCount":66},[],{"intervention":716,"totalTrials":62,"cells":758},{"EARLY_PHASE1":759,"PHASE1":761,"PHASE2":763,"PHASE3":765,"PHASE4":771,"NA":773},{"trials":760,"activeCount":66},[],{"trials":762,"activeCount":66},[],{"trials":764,"activeCount":66},[],{"trials":766,"activeCount":66},[767],{"nctId":706,"briefTitle":707,"status":196,"phases":768,"primaryCompletion":709,"completion":420,"start":710,"enrollment":374,"conditions":769,"interventions":770},[56,57],[712],[695,714,715,716],{"trials":772,"activeCount":66},[],{"trials":774,"activeCount":66},[],{"intervention":471,"totalTrials":62,"cells":776},{"EARLY_PHASE1":777,"PHASE1":779,"PHASE2":781,"PHASE3":783,"PHASE4":789,"NA":791},{"trials":778,"activeCount":66},[],{"trials":780,"activeCount":66},[],{"trials":782,"activeCount":66},[],{"trials":784,"activeCount":66},[785],{"nctId":463,"briefTitle":464,"status":161,"phases":786,"primaryCompletion":466,"start":467,"enrollment":468,"conditions":787,"interventions":788},[56,57],[25],[471,472,442],{"trials":790,"activeCount":66},[],{"trials":792,"activeCount":66},[],{"intervention":472,"totalTrials":62,"cells":794},{"EARLY_PHASE1":795,"PHASE1":797,"PHASE2":799,"PHASE3":801,"PHASE4":807,"NA":809},{"trials":796,"activeCount":66},[],{"trials":798,"activeCount":66},[],{"trials":800,"activeCount":66},[],{"trials":802,"activeCount":66},[803],{"nctId":463,"briefTitle":464,"status":161,"phases":804,"primaryCompletion":466,"start":467,"enrollment":468,"conditions":805,"interventions":806},[56,57],[25],[471,472,442],{"trials":808,"activeCount":66},[],{"trials":810,"activeCount":66},[],{"intervention":812,"totalTrials":62,"cells":813},"Depomedrol",{"EARLY_PHASE1":814,"PHASE1":816,"PHASE2":818,"PHASE3":820,"PHASE4":831,"NA":833},{"trials":815,"activeCount":66},[],{"trials":817,"activeCount":66},[],{"trials":819,"activeCount":66},[],{"trials":821,"activeCount":66},[822],{"nctId":823,"briefTitle":824,"status":196,"phases":825,"primaryCompletion":826,"completion":826,"start":827,"enrollment":12,"conditions":828,"interventions":830},"NCT01986465","Effectiveness of Steroid Injection in Treating Patients With Lateral Epicondylitis",[56,57],"2013-11","2013-05",[829],"Lateral Epicondylitis",[812],{"trials":832,"activeCount":66},[],{"trials":834,"activeCount":66},[],{"intervention":836,"totalTrials":62,"cells":837},"Ibuprofen 800 mg",{"EARLY_PHASE1":838,"PHASE1":840,"PHASE2":842,"PHASE3":844,"PHASE4":859,"NA":861},{"trials":839,"activeCount":66},[],{"trials":841,"activeCount":66},[],{"trials":843,"activeCount":66},[],{"trials":845,"activeCount":66},[846],{"nctId":847,"briefTitle":848,"status":196,"phases":849,"primaryCompletion":850,"completion":851,"start":852,"enrollment":853,"conditions":854,"interventions":856},"NCT05630222","Evaluation of Effect of Intravenous Morphine vs Intravenous Ibuprofen and Acetaminophen vs Intravenous Ibuprofen",[57],"2023-02-15","2023-03-15","2022-03-15",150,[203,855],"Acute Pain Due to Trauma",[836,857,858],"Morphine Sulfate","Ibuprofen 400 mg plus Acetaminophen 1000 mg",{"trials":860,"activeCount":66},[],{"trials":862,"activeCount":66},[],{"intervention":857,"totalTrials":62,"cells":864},{"EARLY_PHASE1":865,"PHASE1":867,"PHASE2":869,"PHASE3":871,"PHASE4":877,"NA":879},{"trials":866,"activeCount":66},[],{"trials":868,"activeCount":66},[],{"trials":870,"activeCount":66},[],{"trials":872,"activeCount":66},[873],{"nctId":847,"briefTitle":848,"status":196,"phases":874,"primaryCompletion":850,"completion":851,"start":852,"enrollment":853,"conditions":875,"interventions":876},[57],[203,855],[836,857,858],{"trials":878,"activeCount":66},[],{"trials":880,"activeCount":66},[],{"intervention":858,"totalTrials":62,"cells":882},{"EARLY_PHASE1":883,"PHASE1":885,"PHASE2":887,"PHASE3":889,"PHASE4":895,"NA":897},{"trials":884,"activeCount":66},[],{"trials":886,"activeCount":66},[],{"trials":888,"activeCount":66},[],{"trials":890,"activeCount":66},[891],{"nctId":847,"briefTitle":848,"status":196,"phases":892,"primaryCompletion":850,"completion":851,"start":852,"enrollment":853,"conditions":893,"interventions":894},[57],[203,855],[836,857,858],{"trials":896,"activeCount":66},[],{"trials":898,"activeCount":66},[],{"intervention":206,"totalTrials":62,"cells":900},{"EARLY_PHASE1":901,"PHASE1":903,"PHASE2":905,"PHASE3":907,"PHASE4":913,"NA":915},{"trials":902,"activeCount":66},[],{"trials":904,"activeCount":66},[],{"trials":906,"activeCount":66},[],{"trials":908,"activeCount":66},[909],{"nctId":194,"briefTitle":195,"status":196,"phases":910,"primaryCompletion":198,"completion":199,"start":200,"enrollment":201,"conditions":911,"interventions":912},[57],[203,204],[206,183],{"trials":914,"activeCount":66},[],{"trials":916,"activeCount":66},[],{"intervention":918,"totalTrials":62,"cells":919},"Probiotic",{"EARLY_PHASE1":920,"PHASE1":922,"PHASE2":924,"PHASE3":926,"PHASE4":937,"NA":939},{"trials":921,"activeCount":66},[],{"trials":923,"activeCount":66},[],{"trials":925,"activeCount":66},[],{"trials":927,"activeCount":66},[928],{"nctId":929,"briefTitle":930,"status":196,"phases":931,"primaryCompletion":347,"completion":228,"start":932,"enrollment":933,"conditions":934,"interventions":936},"NCT01837472","Probiotics in the Treatment of Irritable Bowel Syndrome",[56,57],"2012-04",132,[935],"Irritable Bowel Syndrome",[918],{"trials":938,"activeCount":66},[],{"trials":940,"activeCount":66},[],{"intervention":942,"totalTrials":62,"cells":943},"Edaravone",{"EARLY_PHASE1":944,"PHASE1":946,"PHASE2":948,"PHASE3":950,"PHASE4":963,"NA":965},{"trials":945,"activeCount":66},[],{"trials":947,"activeCount":66},[],{"trials":949,"activeCount":66},[],{"trials":951,"activeCount":66},[952],{"nctId":953,"briefTitle":954,"status":161,"phases":955,"primaryCompletion":956,"completion":957,"start":958,"enrollment":117,"conditions":959,"interventions":961},"NCT03272802","Treatment Effect of Edaravone in Patients With Amyotrophic Lateral Sclerosis (ALS)",[56,57],"2019-03-16","2019-09-16","2017-03-16",[960],"Neuromuscular Diseases",[942,962],"Riluzole",{"trials":964,"activeCount":66},[],{"trials":966,"activeCount":66},[],{"intervention":962,"totalTrials":62,"cells":968},{"EARLY_PHASE1":969,"PHASE1":971,"PHASE2":973,"PHASE3":975,"PHASE4":981,"NA":983},{"trials":970,"activeCount":66},[],{"trials":972,"activeCount":66},[],{"trials":974,"activeCount":66},[],{"trials":976,"activeCount":66},[977],{"nctId":953,"briefTitle":954,"status":161,"phases":978,"primaryCompletion":956,"completion":957,"start":958,"enrollment":117,"conditions":979,"interventions":980},[56,57],[960],[942,962],{"trials":982,"activeCount":66},[],{"trials":984,"activeCount":66},[],{"intervention":986,"totalTrials":62,"cells":987},"Sodium Hyaluronate",{"EARLY_PHASE1":988,"PHASE1":990,"PHASE2":992,"PHASE3":994,"PHASE4":1005,"NA":1007},{"trials":989,"activeCount":66},[],{"trials":991,"activeCount":66},[],{"trials":993,"activeCount":66},[],{"trials":995,"activeCount":66},[996],{"nctId":997,"briefTitle":998,"status":161,"phases":999,"primaryCompletion":227,"completion":227,"start":321,"enrollment":1000,"conditions":1001,"interventions":1003},"NCT01735058","Ultrasonography Guided Subacromial Sodium Hyaluronate Injection in Rotator Cuff Disease",[56,57],48,[1002],"Subacromial Impingement Syndrome",[986,1004],"Normal saline",{"trials":1006,"activeCount":66},[],{"trials":1008,"activeCount":66},[],{"intervention":1010,"totalTrials":62,"cells":1011},"Fingolimod",{"EARLY_PHASE1":1012,"PHASE1":1014,"PHASE2":1016,"PHASE3":1018,"PHASE4":1030,"NA":1032},{"trials":1013,"activeCount":66},[],{"trials":1015,"activeCount":66},[],{"trials":1017,"activeCount":66},[],{"trials":1019,"activeCount":66},[1020],{"nctId":1021,"briefTitle":1022,"status":196,"phases":1023,"primaryCompletion":1024,"completion":1025,"start":1026,"enrollment":1027,"conditions":1028,"interventions":1029},"NCT02939079","Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis Patients",[56,57],"2016-09","2016-10","2015-04",50,[20],[1010],{"trials":1031,"activeCount":66},[],{"trials":1033,"activeCount":66},[],{"intervention":1035,"totalTrials":62,"cells":1036},"prepared drop of medroxy progestrone acetat 1%",{"EARLY_PHASE1":1037,"PHASE1":1039,"PHASE2":1041,"PHASE3":1043,"PHASE4":1056,"NA":1058},{"trials":1038,"activeCount":66},[],{"trials":1040,"activeCount":66},[],{"trials":1042,"activeCount":66},[],{"trials":1044,"activeCount":66},[1045],{"nctId":1046,"briefTitle":1047,"status":196,"phases":1048,"primaryCompletion":1049,"completion":1050,"start":1051,"enrollment":1052,"conditions":1053,"interventions":1055},"NCT05973253","Evaluation of Efficacy and Safety of Topical 1% Medroxyprogesterone in the Corneal Epithelium Healing After PRK",[56,57],"2023-06-21","2023-07-06","2023-04-21",74,[1054],"Photorefractive Keratectomy",[1035],{"trials":1057,"activeCount":66},[],{"trials":1059,"activeCount":66},[],{"intervention":1061,"totalTrials":62,"cells":1062},"2% lidocaine with 1:80,000 epinephrine",{"EARLY_PHASE1":1063,"PHASE1":1065,"PHASE2":1067,"PHASE3":1069,"PHASE4":1081,"NA":1083},{"trials":1064,"activeCount":66},[],{"trials":1066,"activeCount":66},[],{"trials":1068,"activeCount":66},[],{"trials":1070,"activeCount":66},[1071],{"nctId":1072,"briefTitle":1073,"status":196,"phases":1074,"primaryCompletion":1075,"completion":530,"start":1076,"enrollment":1077,"conditions":1078,"interventions":1079},"NCT03531970","Effect of Lidocaine\u002FDexamethasone on the Success of IANB",[56,57],"2017-08-01","2016-08-01",100,[18],[1061,1080],"Dexamethasone",{"trials":1082,"activeCount":66},[],{"trials":1084,"activeCount":66},[],{"intervention":1080,"totalTrials":62,"cells":1086},{"EARLY_PHASE1":1087,"PHASE1":1089,"PHASE2":1091,"PHASE3":1093,"PHASE4":1099,"NA":1101},{"trials":1088,"activeCount":66},[],{"trials":1090,"activeCount":66},[],{"trials":1092,"activeCount":66},[],{"trials":1094,"activeCount":66},[1095],{"nctId":1072,"briefTitle":1073,"status":196,"phases":1096,"primaryCompletion":1075,"completion":530,"start":1076,"enrollment":1077,"conditions":1097,"interventions":1098},[56,57],[18],[1061,1080],{"trials":1100,"activeCount":66},[],{"trials":1102,"activeCount":66},[],{"intervention":1104,"totalTrials":62,"cells":1105},"Niacin skin test",{"EARLY_PHASE1":1106,"PHASE1":1108,"PHASE2":1110,"PHASE3":1112,"PHASE4":1122,"NA":1124},{"trials":1107,"activeCount":66},[],{"trials":1109,"activeCount":66},[],{"trials":1111,"activeCount":66},[],{"trials":1113,"activeCount":66},[1114],{"nctId":1115,"briefTitle":1116,"status":196,"phases":1117,"primaryCompletion":212,"completion":212,"start":1118,"enrollment":1077,"conditions":1119,"interventions":1121},"NCT02458924","Niacin Skin Flush Response in Patients With Schizophrenia",[56,57],"2014-01",[1120],"Schizophrenia",[1104],{"trials":1123,"activeCount":66},[],{"trials":1125,"activeCount":66},[],{"intervention":535,"totalTrials":62,"cells":1127},{"EARLY_PHASE1":1128,"PHASE1":1130,"PHASE2":1132,"PHASE3":1134,"PHASE4":1140,"NA":1142},{"trials":1129,"activeCount":66},[],{"trials":1131,"activeCount":66},[],{"trials":1133,"activeCount":66},[],{"trials":1135,"activeCount":66},[1136],{"nctId":525,"briefTitle":526,"status":196,"phases":1137,"primaryCompletion":528,"completion":529,"start":530,"enrollment":531,"conditions":1138,"interventions":1139},[56,57],[533],[514,535],{"trials":1141,"activeCount":66},[],{"trials":1143,"activeCount":66},[],{"intervention":1145,"totalTrials":62,"cells":1146},"Calcipotriol plus Nicotinamide",{"EARLY_PHASE1":1147,"PHASE1":1149,"PHASE2":1151,"PHASE3":1153,"PHASE4":1164,"NA":1166},{"trials":1148,"activeCount":66},[],{"trials":1150,"activeCount":66},[],{"trials":1152,"activeCount":66},[],{"trials":1154,"activeCount":66},[1155],{"nctId":1156,"briefTitle":1157,"status":196,"phases":1158,"primaryCompletion":227,"completion":227,"start":710,"enrollment":1159,"conditions":1160,"interventions":1162},"NCT01763424","Nicotinamide in the Treatment of Psoriasis",[56,57],66,[1161],"Psoriasis",[1145,1163],"Calcipotriol",{"trials":1165,"activeCount":66},[],{"trials":1167,"activeCount":66},[],{"intervention":1163,"totalTrials":62,"cells":1169},{"EARLY_PHASE1":1170,"PHASE1":1172,"PHASE2":1174,"PHASE3":1176,"PHASE4":1182,"NA":1184},{"trials":1171,"activeCount":66},[],{"trials":1173,"activeCount":66},[],{"trials":1175,"activeCount":66},[],{"trials":1177,"activeCount":66},[1178],{"nctId":1156,"briefTitle":1157,"status":196,"phases":1179,"primaryCompletion":227,"completion":227,"start":710,"enrollment":1159,"conditions":1180,"interventions":1181},[56,57],[1161],[1145,1163],{"trials":1183,"activeCount":66},[],{"trials":1185,"activeCount":66},[],{"intervention":1187,"totalTrials":62,"cells":1188},"Pyruvic acid",{"EARLY_PHASE1":1189,"PHASE1":1191,"PHASE2":1193,"PHASE3":1195,"PHASE4":1206,"NA":1208},{"trials":1190,"activeCount":66},[],{"trials":1192,"activeCount":66},[],{"trials":1194,"activeCount":66},[],{"trials":1196,"activeCount":66},[1197],{"nctId":1198,"briefTitle":1199,"status":161,"phases":1200,"primaryCompletion":212,"completion":212,"start":1201,"enrollment":213,"conditions":1202,"interventions":1204},"NCT02151630","Pyruvic Acid Versus Salicylic Acid Preparation in Treatment of Plantar Warts",[56,57],"2014-05",[1203],"Plantar Wart",[1187,1205],"Salicylic Acid",{"trials":1207,"activeCount":66},[],{"trials":1209,"activeCount":66},[],{"intervention":1205,"totalTrials":62,"cells":1211},{"EARLY_PHASE1":1212,"PHASE1":1214,"PHASE2":1216,"PHASE3":1218,"PHASE4":1224,"NA":1226},{"trials":1213,"activeCount":66},[],{"trials":1215,"activeCount":66},[],{"trials":1217,"activeCount":66},[],{"trials":1219,"activeCount":66},[1220],{"nctId":1198,"briefTitle":1199,"status":161,"phases":1221,"primaryCompletion":212,"completion":212,"start":1201,"enrollment":213,"conditions":1222,"interventions":1223},[56,57],[1203],[1187,1205],{"trials":1225,"activeCount":66},[],{"trials":1227,"activeCount":66},[],{"intervention":1229,"totalTrials":62,"cells":1230},"Ketamine Hydrochloride 50Mg\u002F1mL Solution for",{"EARLY_PHASE1":1231,"PHASE1":1233,"PHASE2":1235,"PHASE3":1237,"PHASE4":1251,"NA":1253},{"trials":1232,"activeCount":66},[],{"trials":1234,"activeCount":66},[],{"trials":1236,"activeCount":66},[],{"trials":1238,"activeCount":66},[1239],{"nctId":1240,"briefTitle":1241,"status":161,"phases":1242,"primaryCompletion":1243,"completion":1244,"start":1245,"enrollment":1246,"conditions":1247,"interventions":1249},"NCT03499886","Low-Dose Intravenous Ketamine Bolus Versus Conventional Technique",[56,57],"2018-04-28","2018-05-14","2017-01-17",198,[1248],"Procedural Sedation",[1229,1250],"Ketamine Hcl 50Mg\u002FMl Inj",{"trials":1252,"activeCount":66},[],{"trials":1254,"activeCount":66},[],{"intervention":1250,"totalTrials":62,"cells":1256},{"EARLY_PHASE1":1257,"PHASE1":1259,"PHASE2":1261,"PHASE3":1263,"PHASE4":1269,"NA":1271},{"trials":1258,"activeCount":66},[],{"trials":1260,"activeCount":66},[],{"trials":1262,"activeCount":66},[],{"trials":1264,"activeCount":66},[1265],{"nctId":1240,"briefTitle":1241,"status":161,"phases":1266,"primaryCompletion":1243,"completion":1244,"start":1245,"enrollment":1246,"conditions":1267,"interventions":1268},[56,57],[1248],[1229,1250],{"trials":1270,"activeCount":66},[],{"trials":1272,"activeCount":66},[],{"intervention":547,"totalTrials":62,"cells":1274},{"EARLY_PHASE1":1275,"PHASE1":1277,"PHASE2":1279,"PHASE3":1281,"PHASE4":1287,"NA":1289},{"trials":1276,"activeCount":66},[],{"trials":1278,"activeCount":66},[],{"trials":1280,"activeCount":66},[],{"trials":1282,"activeCount":66},[1283],{"nctId":537,"briefTitle":538,"status":196,"phases":1284,"primaryCompletion":540,"completion":541,"start":542,"enrollment":543,"conditions":1285,"interventions":1286},[56,57],[545],[547,514],{"trials":1288,"activeCount":66},[],{"trials":1290,"activeCount":66},[],{"intervention":1292,"totalTrials":62,"cells":1293},"Pilocarpine Ophthalmic",{"EARLY_PHASE1":1294,"PHASE1":1296,"PHASE2":1298,"PHASE3":1300,"PHASE4":1314,"NA":1316},{"trials":1295,"activeCount":66},[],{"trials":1297,"activeCount":66},[],{"trials":1299,"activeCount":66},[],{"trials":1301,"activeCount":66},[1302],{"nctId":1303,"briefTitle":1304,"status":161,"phases":1305,"primaryCompletion":1306,"completion":1307,"start":1308,"enrollment":1309,"conditions":1310,"interventions":1313},"NCT05578001","Efficacy of Pilocarpine 1% in Presbyopia",[57],"2022-12-30","2023-03-30","2022-07-01",25,[1311,1312],"Presbyopia","Pseudophakia",[1292],{"trials":1315,"activeCount":66},[],{"trials":1317,"activeCount":66},[],{"intervention":1319,"totalTrials":62,"cells":1320},"Polypill",{"EARLY_PHASE1":1321,"PHASE1":1323,"PHASE2":1325,"PHASE3":1327,"PHASE4":1342,"NA":1344},{"trials":1322,"activeCount":66},[],{"trials":1324,"activeCount":66},[],{"trials":1326,"activeCount":66},[],{"trials":1328,"activeCount":66},[1329],{"nctId":1330,"briefTitle":1331,"status":161,"phases":1332,"primaryCompletion":1333,"completion":1334,"start":1335,"enrollment":1336,"conditions":1337,"interventions":1341},"NCT03541109","A Polypill for Secondary Prevention of Ischemic Heart Disease",[57],"2023-08","2024-08","2019-05-20",1200,[1338,1339,1340],"Acute Myocardial Infarction","ST Elevation Myocardial Infarction","Non-ST Elevation Myocardial Infarction",[1319],{"trials":1343,"activeCount":66},[],{"trials":1345,"activeCount":66},[],{"intervention":218,"totalTrials":62,"cells":1347},{"EARLY_PHASE1":1348,"PHASE1":1350,"PHASE2":1352,"PHASE3":1354,"PHASE4":1360,"NA":1362},{"trials":1349,"activeCount":66},[],{"trials":1351,"activeCount":66},[],{"trials":1353,"activeCount":66},[],{"trials":1355,"activeCount":66},[1356],{"nctId":208,"briefTitle":209,"status":196,"phases":1357,"primaryCompletion":211,"completion":211,"start":212,"enrollment":213,"conditions":1358,"interventions":1359},[56,57],[215],[217,218,183,219,220],{"trials":1361,"activeCount":66},[],{"trials":1363,"activeCount":66},[],{"intervention":219,"totalTrials":62,"cells":1365},{"EARLY_PHASE1":1366,"PHASE1":1368,"PHASE2":1370,"PHASE3":1372,"PHASE4":1378,"NA":1380},{"trials":1367,"activeCount":66},[],{"trials":1369,"activeCount":66},[],{"trials":1371,"activeCount":66},[],{"trials":1373,"activeCount":66},[1374],{"nctId":208,"briefTitle":209,"status":196,"phases":1375,"primaryCompletion":211,"completion":211,"start":212,"enrollment":213,"conditions":1376,"interventions":1377},[56,57],[215],[217,218,183,219,220],{"trials":1379,"activeCount":66},[],{"trials":1381,"activeCount":66},[],{"intervention":220,"totalTrials":62,"cells":1383},{"EARLY_PHASE1":1384,"PHASE1":1386,"PHASE2":1388,"PHASE3":1390,"PHASE4":1396,"NA":1398},{"trials":1385,"activeCount":66},[],{"trials":1387,"activeCount":66},[],{"trials":1389,"activeCount":66},[],{"trials":1391,"activeCount":66},[1392],{"nctId":208,"briefTitle":209,"status":196,"phases":1393,"primaryCompletion":211,"completion":211,"start":212,"enrollment":213,"conditions":1394,"interventions":1395},[56,57],[215],[217,218,183,219,220],{"trials":1397,"activeCount":66},[],{"trials":1399,"activeCount":66},[],{"intervention":436,"totalTrials":62,"cells":1401},{"EARLY_PHASE1":1402,"PHASE1":1404,"PHASE2":1406,"PHASE3":1408,"PHASE4":1414,"NA":1416},{"trials":1403,"activeCount":66},[],{"trials":1405,"activeCount":66},[],{"trials":1407,"activeCount":66},[],{"trials":1409,"activeCount":66},[1410],{"nctId":428,"briefTitle":429,"status":196,"phases":1411,"primaryCompletion":431,"completion":431,"start":432,"enrollment":433,"conditions":1412,"interventions":1413},[56,57],[22],[406,436],{"trials":1415,"activeCount":66},[],{"trials":1417,"activeCount":66},[],{"intervention":1419,"totalTrials":62,"cells":1420},"Levothyroxine",{"EARLY_PHASE1":1421,"PHASE1":1423,"PHASE2":1425,"PHASE3":1427,"PHASE4":1436,"NA":1438},{"trials":1422,"activeCount":66},[],{"trials":1424,"activeCount":66},[],{"trials":1426,"activeCount":66},[],{"trials":1428,"activeCount":66},[1429],{"nctId":1430,"briefTitle":1431,"status":196,"phases":1432,"primaryCompletion":456,"completion":456,"start":827,"enrollment":1027,"conditions":1433,"interventions":1435},"NCT02090907","Effects of Levothyroxine on Endothelial Function of Patients With Subclinical Hypothyroidism",[56,57],[1434],"Subclinical Hypothyroidism",[1419],{"trials":1437,"activeCount":66},[],{"trials":1439,"activeCount":66},[],{"intervention":1441,"totalTrials":23,"cells":1442},"Triamcinolone Acetonide",{"EARLY_PHASE1":1443,"PHASE1":1445,"PHASE2":1447,"PHASE3":1465,"PHASE4":1467,"NA":1469},{"trials":1444,"activeCount":66},[],{"trials":1446,"activeCount":66},[],{"trials":1448,"activeCount":66},[1449,1457],{"nctId":1450,"briefTitle":1451,"status":196,"phases":1452,"primaryCompletion":456,"completion":456,"start":827,"enrollment":213,"conditions":1453,"interventions":1455},"NCT02075749","Comparing Triamcinolone Acetonide Mucoadhesive Films With Licorice Mucoadhesive Films",[55,56],[1454],"Mucositis",[1441,1456],"licorice mucoadhesive films",{"nctId":1458,"briefTitle":1459,"status":196,"phases":1460,"primaryCompletion":211,"completion":1026,"start":1118,"enrollment":213,"conditions":1461,"interventions":1463},"NCT02453503","Comparison of Triamcinolone Acetonide Mucoadhesive Film and Licorice Mucoadhesive Film Effect on Lichen Planus",[56],[1462],"Oral Lichen Planus",[1464,1441],"Licorice",{"trials":1466,"activeCount":66},[],{"trials":1468,"activeCount":66},[],{"trials":1470,"activeCount":66},[],{"intervention":1472,"totalTrials":23,"cells":1473},"Cefazolin",{"EARLY_PHASE1":1474,"PHASE1":1476,"PHASE2":1478,"PHASE3":1503,"PHASE4":1505,"NA":1507},{"trials":1475,"activeCount":66},[],{"trials":1477,"activeCount":66},[],{"trials":1479,"activeCount":66},[1480,1492],{"nctId":1481,"briefTitle":1482,"status":161,"phases":1483,"primaryCompletion":1484,"completion":1485,"start":1486,"enrollment":1487,"conditions":1488,"interventions":1490},"NCT03466645","The Effectiveness of Vancomycin in Comarison With Cefazolin in Prevention of SSI After Craniotomy",[55,56],"2019-04-01","2019-08-01","2018-04-01",126,[1489],"Elective Craniotomy-candidated Patients",[1491,1472],"Vancomycin",{"nctId":1493,"briefTitle":1494,"status":196,"phases":1495,"primaryCompletion":1496,"completion":1497,"start":1498,"enrollment":230,"conditions":1499,"interventions":1501},"NCT02493894","The Effect of Bowel Preparation on Perioperative Bleeding",[55,56],"2015-05","2015-06","2014-07",[1500],"Surgery",[1502,1472],"PEG",{"trials":1504,"activeCount":66},[],{"trials":1506,"activeCount":66},[],{"trials":1508,"activeCount":66},[],{"intervention":1456,"totalTrials":62,"cells":1510},{"EARLY_PHASE1":1511,"PHASE1":1513,"PHASE2":1515,"PHASE3":1521,"PHASE4":1523,"NA":1525},{"trials":1512,"activeCount":66},[],{"trials":1514,"activeCount":66},[],{"trials":1516,"activeCount":66},[1517],{"nctId":1450,"briefTitle":1451,"status":196,"phases":1518,"primaryCompletion":456,"completion":456,"start":827,"enrollment":213,"conditions":1519,"interventions":1520},[55,56],[1454],[1441,1456],{"trials":1522,"activeCount":66},[],{"trials":1524,"activeCount":66},[],{"trials":1526,"activeCount":66},[],{"intervention":1528,"totalTrials":62,"cells":1529},"Multimodal Drug",{"EARLY_PHASE1":1530,"PHASE1":1532,"PHASE2":1534,"PHASE3":1550,"PHASE4":1552,"NA":1554},{"trials":1531,"activeCount":66},[],{"trials":1533,"activeCount":66},[],{"trials":1535,"activeCount":66},[1536],{"nctId":1537,"briefTitle":1538,"status":196,"phases":1539,"primaryCompletion":1540,"completion":1541,"start":1542,"enrollment":1543,"conditions":1544,"interventions":1547},"NCT05324995","Peri-Articular-Multimodal Drug and Oral Celecoxib in Management of Postoperative Pain of Total Knee Arthroplasty",[56],"2022-02-01","2022-03-01","2021-01-01",146,[1545,1546],"Postoperative Pain","Total Knee Arthroplasty",[1528,1548,1549],"epinephrine","celecoxib",{"trials":1551,"activeCount":66},[],{"trials":1553,"activeCount":66},[],{"trials":1555,"activeCount":66},[],{"intervention":1549,"totalTrials":62,"cells":1557},{"EARLY_PHASE1":1558,"PHASE1":1560,"PHASE2":1562,"PHASE3":1568,"PHASE4":1570,"NA":1572},{"trials":1559,"activeCount":66},[],{"trials":1561,"activeCount":66},[],{"trials":1563,"activeCount":66},[1564],{"nctId":1537,"briefTitle":1538,"status":196,"phases":1565,"primaryCompletion":1540,"completion":1541,"start":1542,"enrollment":1543,"conditions":1566,"interventions":1567},[56],[1545,1546],[1528,1548,1549],{"trials":1569,"activeCount":66},[],{"trials":1571,"activeCount":66},[],{"trials":1573,"activeCount":66},[],{"intervention":1575,"totalTrials":62,"cells":1576},"Systemic Analgesia",{"EARLY_PHASE1":1577,"PHASE1":1579,"PHASE2":1581,"PHASE3":1592,"PHASE4":1594,"NA":1596},{"trials":1578,"activeCount":66},[],{"trials":1580,"activeCount":66},[],{"trials":1582,"activeCount":66},[1583],{"nctId":1584,"briefTitle":1585,"status":161,"phases":1586,"primaryCompletion":1587,"completion":1588,"start":1589,"enrollment":399,"conditions":1590,"interventions":1591},"NCT03349216","Bier's Block Versus Systemic Analgesia",[56],"2018-01","2018-04","2017-10-20",[27],[1575],{"trials":1593,"activeCount":66},[],{"trials":1595,"activeCount":66},[],{"trials":1597,"activeCount":66},[],{"intervention":1599,"totalTrials":62,"cells":1600},"Ginseng",{"EARLY_PHASE1":1601,"PHASE1":1603,"PHASE2":1605,"PHASE3":1615,"PHASE4":1617,"NA":1619},{"trials":1602,"activeCount":66},[],{"trials":1604,"activeCount":66},[],{"trials":1606,"activeCount":66},[1607],{"nctId":1608,"briefTitle":1609,"status":196,"phases":1610,"primaryCompletion":1611,"completion":1611,"start":1612,"enrollment":213,"conditions":1613,"interventions":1614},"NCT01712373","Ginseng in Treatment of Fatigue in Multiple Sclerosis",[56],"2011-04","2010-12",[31],[1599],{"trials":1616,"activeCount":66},[],{"trials":1618,"activeCount":66},[],{"trials":1620,"activeCount":66},[],{"intervention":1491,"totalTrials":62,"cells":1622},{"EARLY_PHASE1":1623,"PHASE1":1625,"PHASE2":1627,"PHASE3":1633,"PHASE4":1635,"NA":1637},{"trials":1624,"activeCount":66},[],{"trials":1626,"activeCount":66},[],{"trials":1628,"activeCount":66},[1629],{"nctId":1481,"briefTitle":1482,"status":161,"phases":1630,"primaryCompletion":1484,"completion":1485,"start":1486,"enrollment":1487,"conditions":1631,"interventions":1632},[55,56],[1489],[1491,1472],{"trials":1634,"activeCount":66},[],{"trials":1636,"activeCount":66},[],{"trials":1638,"activeCount":66},[],{"intervention":1640,"totalTrials":62,"cells":1641},"KETAMINE, PROPOFOL, THIOPENTAL",{"EARLY_PHASE1":1642,"PHASE1":1644,"PHASE2":1646,"PHASE3":1657,"PHASE4":1659,"NA":1661},{"trials":1643,"activeCount":66},[],{"trials":1645,"activeCount":66},[],{"trials":1647,"activeCount":66},[1648],{"nctId":1649,"briefTitle":1650,"status":196,"phases":1651,"completion":491,"start":1652,"enrollment":1653,"conditions":1654,"interventions":1656},"NCT00478907","Prevention of Complications of Eye Surgery",[56],"2004-03",300,[1655],"Strabismus",[1640],{"trials":1658,"activeCount":66},[],{"trials":1660,"activeCount":66},[],{"trials":1662,"activeCount":66},[],{"intervention":1664,"totalTrials":62,"cells":1665},"use of magnesium sulfate with lidocaine in inferior alveolar nerve block",{"EARLY_PHASE1":1666,"PHASE1":1668,"PHASE2":1670,"PHASE3":1680,"PHASE4":1682,"NA":1684},{"trials":1667,"activeCount":66},[],{"trials":1669,"activeCount":66},[],{"trials":1671,"activeCount":66},[1672],{"nctId":1673,"briefTitle":1674,"status":196,"phases":1675,"primaryCompletion":1676,"completion":1676,"start":1677,"enrollment":23,"conditions":1678,"interventions":1679},"NCT03262857","Effect of Lidocaine With Magnesium Sulfate on the Success of the Inferior Alveolar Nerve Block",[56],"2018-09-21","2016-09-21",[18],[1664],{"trials":1681,"activeCount":66},[],{"trials":1683,"activeCount":66},[],{"trials":1685,"activeCount":66},[],{"intervention":1687,"totalTrials":62,"cells":1688},"Doxepin cream 5%",{"EARLY_PHASE1":1689,"PHASE1":1691,"PHASE2":1693,"PHASE3":1703,"PHASE4":1705,"NA":1707},{"trials":1690,"activeCount":66},[],{"trials":1692,"activeCount":66},[],{"trials":1694,"activeCount":66},[1695],{"nctId":1696,"briefTitle":1697,"status":161,"phases":1698,"primaryCompletion":1699,"completion":1699,"start":1496,"enrollment":213,"conditions":1700,"interventions":1702},"NCT02447211","Topical Doxepin for Radiation-induced Dermatitis",[56],"2019-01",[1701],"Breast Cancer",[1687],{"trials":1704,"activeCount":66},[],{"trials":1706,"activeCount":66},[],{"trials":1708,"activeCount":66},[],{"intervention":1464,"totalTrials":62,"cells":1710},{"EARLY_PHASE1":1711,"PHASE1":1713,"PHASE2":1715,"PHASE3":1721,"PHASE4":1723,"NA":1725},{"trials":1712,"activeCount":66},[],{"trials":1714,"activeCount":66},[],{"trials":1716,"activeCount":66},[1717],{"nctId":1458,"briefTitle":1459,"status":196,"phases":1718,"primaryCompletion":211,"completion":1026,"start":1118,"enrollment":213,"conditions":1719,"interventions":1720},[56],[1462],[1464,1441],{"trials":1722,"activeCount":66},[],{"trials":1724,"activeCount":66},[],{"trials":1726,"activeCount":66},[],{"intervention":1728,"totalTrials":62,"cells":1729},"Growh hormone",{"EARLY_PHASE1":1730,"PHASE1":1732,"PHASE2":1734,"PHASE3":1749,"PHASE4":1751,"NA":1753},{"trials":1731,"activeCount":66},[],{"trials":1733,"activeCount":66},[],{"trials":1735,"activeCount":66},[1736],{"nctId":1737,"briefTitle":1738,"status":196,"phases":1739,"primaryCompletion":1740,"completion":1741,"start":1742,"enrollment":1743,"conditions":1744,"interventions":1748},"NCT06379659","Effectiveness of Intrauterine Growth Hormone Administration as an add-on Therapy to Conventional Hormone Therapy Compared to Placebo in Patients With Thin Endometrium Undergoing Frozen Thawed Embryo Transfer",[55,56],"2024-07-29","2024-09-14","2024-05-01",54,[1745,1746,1747],"Thin Endometrium","Infertility Female","Infertility",[1728],{"trials":1750,"activeCount":66},[],{"trials":1752,"activeCount":66},[],{"trials":1754,"activeCount":66},[],{"intervention":1502,"totalTrials":62,"cells":1756},{"EARLY_PHASE1":1757,"PHASE1":1759,"PHASE2":1761,"PHASE3":1767,"PHASE4":1769,"NA":1771},{"trials":1758,"activeCount":66},[],{"trials":1760,"activeCount":66},[],{"trials":1762,"activeCount":66},[1763],{"nctId":1493,"briefTitle":1494,"status":196,"phases":1764,"primaryCompletion":1496,"completion":1497,"start":1498,"enrollment":230,"conditions":1765,"interventions":1766},[55,56],[1500],[1502,1472],{"trials":1768,"activeCount":66},[],{"trials":1770,"activeCount":66},[],{"trials":1772,"activeCount":66},[],{"intervention":1774,"totalTrials":62,"cells":1775},"Vitamin D",{"EARLY_PHASE1":1776,"PHASE1":1778,"PHASE2":1780,"PHASE3":1790,"PHASE4":1792,"NA":1794},{"trials":1777,"activeCount":66},[],{"trials":1779,"activeCount":66},[],{"trials":1781,"activeCount":66},[1782],{"nctId":1783,"briefTitle":1784,"status":161,"phases":1785,"primaryCompletion":709,"completion":227,"start":710,"enrollment":213,"conditions":1786,"interventions":1788},"NCT01465893","Effect of Vitamin D on Retinal Changes in Patient With Optic Neuritis by Optic Coherence Tomography",[56],[1787],"Optic Neuritis",[1774,1789],"Vitamin D withheld",{"trials":1791,"activeCount":66},[],{"trials":1793,"activeCount":66},[],{"trials":1795,"activeCount":66},[],{"intervention":1789,"totalTrials":62,"cells":1797},{"EARLY_PHASE1":1798,"PHASE1":1800,"PHASE2":1802,"PHASE3":1808,"PHASE4":1810,"NA":1812},{"trials":1799,"activeCount":66},[],{"trials":1801,"activeCount":66},[],{"trials":1803,"activeCount":66},[1804],{"nctId":1783,"briefTitle":1784,"status":161,"phases":1805,"primaryCompletion":709,"completion":227,"start":710,"enrollment":213,"conditions":1806,"interventions":1807},[56],[1787],[1774,1789],{"trials":1809,"activeCount":66},[],{"trials":1811,"activeCount":66},[],{"trials":1813,"activeCount":66},[],{"intervention":1815,"totalTrials":62,"cells":1816},"metoclopramide, injection,20mg, one time",{"EARLY_PHASE1":1817,"PHASE1":1819,"PHASE2":1821,"PHASE3":1834,"PHASE4":1836,"NA":1838},{"trials":1818,"activeCount":66},[],{"trials":1820,"activeCount":66},[],{"trials":1822,"activeCount":66},[1823],{"nctId":1824,"briefTitle":1825,"status":196,"phases":1826,"primaryCompletion":1827,"completion":1827,"start":1828,"enrollment":1829,"conditions":1830,"interventions":1832},"NCT01791400","Effect of Metoclopramide Versus Sumatriptan for Emergency Department Treatment of Migraine Headache",[56],"2010-11","2009-07",124,[1831],"Migraine Disorders",[1815,1833],"Sumatriptan, injection, 6 mg, one time",{"trials":1835,"activeCount":66},[],{"trials":1837,"activeCount":66},[],{"trials":1839,"activeCount":66},[],{"intervention":1833,"totalTrials":62,"cells":1841},{"EARLY_PHASE1":1842,"PHASE1":1844,"PHASE2":1846,"PHASE3":1852,"PHASE4":1854,"NA":1856},{"trials":1843,"activeCount":66},[],{"trials":1845,"activeCount":66},[],{"trials":1847,"activeCount":66},[1848],{"nctId":1824,"briefTitle":1825,"status":196,"phases":1849,"primaryCompletion":1827,"completion":1827,"start":1828,"enrollment":1829,"conditions":1850,"interventions":1851},[56],[1831],[1815,1833],{"trials":1853,"activeCount":66},[],{"trials":1855,"activeCount":66},[],{"trials":1857,"activeCount":66},[],{"intervention":1859,"totalTrials":62,"cells":1860},"L-carnitine",{"EARLY_PHASE1":1861,"PHASE1":1863,"PHASE2":1865,"PHASE3":1876,"PHASE4":1878,"NA":1880},{"trials":1862,"activeCount":66},[],{"trials":1864,"activeCount":66},[],{"trials":1866,"activeCount":66},[1867],{"nctId":1868,"briefTitle":1869,"status":196,"phases":1870,"primaryCompletion":1871,"completion":1871,"start":1872,"enrollment":1743,"conditions":1873,"interventions":1875},"NCT01278693","Effect of Oral L-carnitine Supplement on Lipid Profile, Anemia, and Quality of Life of Patients",[56],"2010-09","2009-08",[1874],"Complication of Hemodialysis",[1859],{"trials":1877,"activeCount":66},[],{"trials":1879,"activeCount":66},[],{"trials":1881,"activeCount":66},[],{"intervention":1883,"totalTrials":62,"cells":1884},"exosime",{"EARLY_PHASE1":1885,"PHASE1":1887,"PHASE2":1889,"PHASE3":1900,"PHASE4":1902,"NA":1904},{"trials":1886,"activeCount":66},[],{"trials":1888,"activeCount":66},[],{"trials":1890,"activeCount":66},[1891],{"nctId":1892,"briefTitle":1893,"status":161,"phases":1894,"primaryCompletion":1895,"completion":1896,"start":1540,"enrollment":117,"conditions":1897,"interventions":1899},"NCT05813379","Mesenchymal Stem Cells Derived Exosomes in Skin Rejuvenation",[55,56],"2023-07-29","2023-08-30",[1898],"Anti Aging",[1883],{"trials":1901,"activeCount":66},[],{"trials":1903,"activeCount":66},[],{"trials":1905,"activeCount":66},[],{"intervention":1907,"totalTrials":62,"cells":1908},"Vitamin D3 50000 UNT Oral",{"EARLY_PHASE1":1909,"PHASE1":1911,"PHASE2":1913,"PHASE3":1927,"PHASE4":1929,"NA":1931},{"trials":1910,"activeCount":66},[],{"trials":1912,"activeCount":66},[],{"trials":1914,"activeCount":66},[1915],{"nctId":1916,"briefTitle":1917,"status":161,"phases":1918,"primaryCompletion":1919,"completion":1485,"start":1920,"enrollment":399,"conditions":1921,"interventions":1926},"NCT03405207","Vitamin D Deficiency Treatment Outcomes After Non-ST-Segment Elevation Myocardial Infarction",[56],"2018-10-01","2018-05-01",[1922,1923,1924,1925],"Vitamin D Deficiency","Non-ST Elevation Myocardial Infarction (nSTEMI)","Inflammation","Coronary Artery Disease With Myocardial Infarction",[1907],{"trials":1928,"activeCount":66},[],{"trials":1930,"activeCount":66},[],{"trials":1932,"activeCount":66},[],{"intervention":1934,"totalTrials":62,"cells":1935},"1% Azithromycin gel",{"EARLY_PHASE1":1936,"PHASE1":1938,"PHASE2":1940,"PHASE3":1953,"PHASE4":1955,"NA":1957},{"trials":1937,"activeCount":66},[],{"trials":1939,"activeCount":66},[],{"trials":1941,"activeCount":66},[1942],{"nctId":1943,"briefTitle":1944,"status":196,"phases":1945,"primaryCompletion":1946,"completion":228,"start":1947,"enrollment":1948,"conditions":1949,"interventions":1951},"NCT01921738","The Effect of Azithromycin in the Treatment of Chronic Periodontitis",[56],"2013-03","2012-05",80,[1950],"Chronic Periodontitis",[1934,1952],"Azithromycin",{"trials":1954,"activeCount":66},[],{"trials":1956,"activeCount":66},[],{"trials":1958,"activeCount":66},[],{"intervention":1952,"totalTrials":62,"cells":1960},{"EARLY_PHASE1":1961,"PHASE1":1963,"PHASE2":1965,"PHASE3":1971,"PHASE4":1973,"NA":1975},{"trials":1962,"activeCount":66},[],{"trials":1964,"activeCount":66},[],{"trials":1966,"activeCount":66},[1967],{"nctId":1943,"briefTitle":1944,"status":196,"phases":1968,"primaryCompletion":1946,"completion":228,"start":1947,"enrollment":1948,"conditions":1969,"interventions":1970},[56],[1950],[1934,1952],{"trials":1972,"activeCount":66},[],{"trials":1974,"activeCount":66},[],{"trials":1976,"activeCount":66},[],{"intervention":1978,"totalTrials":62,"cells":1979},"Methyldopa",{"EARLY_PHASE1":1980,"PHASE1":1982,"PHASE2":1984,"PHASE3":1994,"PHASE4":1996,"NA":1998},{"trials":1981,"activeCount":66},[],{"trials":1983,"activeCount":66},[],{"trials":1985,"activeCount":66},[1986],{"nctId":1987,"briefTitle":1988,"status":196,"phases":1989,"primaryCompletion":321,"completion":1947,"start":1990,"enrollment":1027,"conditions":1991,"interventions":1993},"NCT01674127","Effect of Methyldopa on Uterine Artery Diameter in Pregnant Women With Mild Preeclampsia",[56],"2011-08",[1992],"Pregnant Women With Mild Preeclampsia",[1978],{"trials":1995,"activeCount":66},[],{"trials":1997,"activeCount":66},[],{"trials":1999,"activeCount":66},[],{"intervention":2001,"totalTrials":62,"cells":2002},"Intranasal naloxone",{"EARLY_PHASE1":2003,"PHASE1":2005,"PHASE2":2007,"PHASE3":2019,"PHASE4":2021,"NA":2023},{"trials":2004,"activeCount":66},[],{"trials":2006,"activeCount":66},[],{"trials":2008,"activeCount":66},[2009],{"nctId":2010,"briefTitle":2011,"status":196,"phases":2012,"primaryCompletion":2013,"completion":2013,"start":2014,"enrollment":1077,"conditions":2015,"interventions":2017},"NCT01293058","Randomized Trial of Intranasal Versus Intravenous Naloxone in Level of Consciousness in Suspected Opioid Overdose",[56],"2007-06","2007-03",[2016],"Morphinan Opioid Overdose",[2001,2018],"Intravenous",{"trials":2020,"activeCount":66},[],{"trials":2022,"activeCount":66},[],{"trials":2024,"activeCount":66},[],{"intervention":2018,"totalTrials":62,"cells":2026},{"EARLY_PHASE1":2027,"PHASE1":2029,"PHASE2":2031,"PHASE3":2037,"PHASE4":2039,"NA":2041},{"trials":2028,"activeCount":66},[],{"trials":2030,"activeCount":66},[],{"trials":2032,"activeCount":66},[2033],{"nctId":2010,"briefTitle":2011,"status":196,"phases":2034,"primaryCompletion":2013,"completion":2013,"start":2014,"enrollment":1077,"conditions":2035,"interventions":2036},[56],[2016],[2001,2018],{"trials":2038,"activeCount":66},[],{"trials":2040,"activeCount":66},[],{"trials":2042,"activeCount":66},[],{"intervention":2044,"totalTrials":62,"cells":2045},"Rivaroxaban",{"EARLY_PHASE1":2046,"PHASE1":2048,"PHASE2":2050,"PHASE3":2063,"PHASE4":2065,"NA":2067},{"trials":2047,"activeCount":66},[],{"trials":2049,"activeCount":66},[],{"trials":2051,"activeCount":66},[2052],{"nctId":2053,"briefTitle":2054,"status":161,"phases":2055,"primaryCompletion":2056,"completion":2057,"start":2058,"enrollment":1027,"conditions":2059,"interventions":2061},"NCT03747081","Efficacy Comparison of Warfarin Versus Rivaroxaban CVT",[55,56],"2020-01-01","2020-05-01","2018-09-01",[2060],"Cerebral Venous Thrombosis",[2044,2062],"Warfarin",{"trials":2064,"activeCount":66},[],{"trials":2066,"activeCount":66},[],{"trials":2068,"activeCount":66},[],{"intervention":2062,"totalTrials":62,"cells":2070},{"EARLY_PHASE1":2071,"PHASE1":2073,"PHASE2":2075,"PHASE3":2081,"PHASE4":2083,"NA":2085},{"trials":2072,"activeCount":66},[],{"trials":2074,"activeCount":66},[],{"trials":2076,"activeCount":66},[2077],{"nctId":2053,"briefTitle":2054,"status":161,"phases":2078,"primaryCompletion":2056,"completion":2057,"start":2058,"enrollment":1027,"conditions":2079,"interventions":2080},[55,56],[2060],[2044,2062],{"trials":2082,"activeCount":66},[],{"trials":2084,"activeCount":66},[],{"trials":2086,"activeCount":66},[],{"intervention":2088,"totalTrials":62,"cells":2089},"Melatonin 10 mg",{"EARLY_PHASE1":2090,"PHASE1":2092,"PHASE2":2094,"PHASE3":2107,"PHASE4":2109,"NA":2111},{"trials":2091,"activeCount":66},[],{"trials":2093,"activeCount":66},[],{"trials":2095,"activeCount":66},[2096],{"nctId":2097,"briefTitle":2098,"status":161,"phases":2099,"primaryCompletion":2100,"completion":2101,"start":2102,"enrollment":2103,"conditions":2104,"interventions":2106},"NCT03894683","Effect of Melatonin on Cardiovascular and Muscle Mass and Function in Patients With Heart Failure",[56],"2020-05","2020-12","2018-11-30",90,[2105],"Heart Failure With Reduced Ejection Fraction",[2088],{"trials":2108,"activeCount":66},[],{"trials":2110,"activeCount":66},[],{"trials":2112,"activeCount":66},[],{"intervention":2114,"totalTrials":62,"cells":2115},"Melatonin",{"EARLY_PHASE1":2116,"PHASE1":2118,"PHASE2":2120,"PHASE3":2128,"PHASE4":2130,"NA":2132},{"trials":2117,"activeCount":66},[],{"trials":2119,"activeCount":66},[],{"trials":2121,"activeCount":66},[2122],{"nctId":2123,"briefTitle":2124,"status":196,"phases":2125,"primaryCompletion":420,"completion":420,"start":1947,"enrollment":137,"conditions":2126,"interventions":2127},"NCT01718678","Effect of Melatonin on Multiple Sclerosis Related Fatigue",[56],[31],[2114],{"trials":2129,"activeCount":66},[],{"trials":2131,"activeCount":66},[],{"trials":2133,"activeCount":66},[],{"intervention":2135,"totalTrials":62,"cells":2136},"atracurium",{"EARLY_PHASE1":2137,"PHASE1":2139,"PHASE2":2141,"PHASE3":2151,"PHASE4":2153,"NA":2155},{"trials":2138,"activeCount":66},[],{"trials":2140,"activeCount":66},[],{"trials":2142,"activeCount":66},[2143],{"nctId":2144,"briefTitle":2145,"status":196,"phases":2146,"primaryCompletion":502,"completion":502,"start":1828,"enrollment":2103,"conditions":2147,"interventions":2149},"NCT01273831","Effect of Cisatracurium Versus Atracurium on Intraocular Pressure in Patients Underwent General Anesthesia",[56],[2148],"Intraocular Pressure",[2135,2150],"cisatracurium",{"trials":2152,"activeCount":66},[],{"trials":2154,"activeCount":66},[],{"trials":2156,"activeCount":66},[],{"intervention":2150,"totalTrials":62,"cells":2158},{"EARLY_PHASE1":2159,"PHASE1":2161,"PHASE2":2163,"PHASE3":2169,"PHASE4":2171,"NA":2173},{"trials":2160,"activeCount":66},[],{"trials":2162,"activeCount":66},[],{"trials":2164,"activeCount":66},[2165],{"nctId":2144,"briefTitle":2145,"status":196,"phases":2166,"primaryCompletion":502,"completion":502,"start":1828,"enrollment":2103,"conditions":2167,"interventions":2168},[56],[2148],[2135,2150],{"trials":2170,"activeCount":66},[],{"trials":2172,"activeCount":66},[],{"trials":2174,"activeCount":66},[],{"intervention":2176,"totalTrials":62,"cells":2177},"Cytarabine",{"EARLY_PHASE1":2178,"PHASE1":2180,"PHASE2":2193,"PHASE3":2195,"PHASE4":2197,"NA":2199},{"trials":2179,"activeCount":66},[],{"trials":2181,"activeCount":66},[2182],{"nctId":2183,"briefTitle":2184,"status":161,"phases":2185,"primaryCompletion":2186,"completion":1025,"start":2187,"enrollment":9,"conditions":2188,"interventions":2191},"NCT02413021","The Effect of Deferasirox on Response Rate of Acute Leukemia Patients Not Treated by Standard Chemotherapy Regimens",[55],"2016-08","2016-05",[2189,2190],"Acute Myeloid Leukemia","Acute Lymphoid Leukemia",[2176,2192],"Deferasirox",{"trials":2194,"activeCount":66},[],{"trials":2196,"activeCount":66},[],{"trials":2198,"activeCount":66},[],{"trials":2200,"activeCount":66},[],{"intervention":2192,"totalTrials":62,"cells":2202},{"EARLY_PHASE1":2203,"PHASE1":2205,"PHASE2":2211,"PHASE3":2213,"PHASE4":2215,"NA":2217},{"trials":2204,"activeCount":66},[],{"trials":2206,"activeCount":66},[2207],{"nctId":2183,"briefTitle":2184,"status":161,"phases":2208,"primaryCompletion":2186,"completion":1025,"start":2187,"enrollment":9,"conditions":2209,"interventions":2210},[55],[2189,2190],[2176,2192],{"trials":2212,"activeCount":66},[],{"trials":2214,"activeCount":66},[],{"trials":2216,"activeCount":66},[],{"trials":2218,"activeCount":66},[],{"intervention":461,"totalTrials":16,"cells":2220},{"EARLY_PHASE1":2221,"PHASE1":2223,"PHASE2":2225,"PHASE3":2227,"PHASE4":2241,"NA":2243},{"trials":2222,"activeCount":66},[],{"trials":2224,"activeCount":66},[],{"trials":2226,"activeCount":66},[],{"trials":2228,"activeCount":66},[2229,2233],{"nctId":453,"briefTitle":454,"status":196,"phases":2230,"primaryCompletion":456,"completion":456,"start":457,"enrollment":458,"conditions":2231,"interventions":2232},[56,57],[25],[461,442],{"nctId":2234,"briefTitle":2235,"status":161,"phases":2236,"primaryCompletion":1201,"start":2237,"conditions":2238,"interventions":2240},"NCT02113540","Assessment of the Effect of Atorvastatin on Prevention of CIN in Patients Undergoing Coronary Angiography",[57],"2012-01",[2239],"Contrast Induced Nephropathy",[461],{"trials":2242,"activeCount":66},[],{"trials":2244,"activeCount":66},[2245],{"nctId":2246,"briefTitle":2247,"status":161,"phases":2248,"primaryCompletion":1118,"start":345,"enrollment":374,"conditions":2249,"interventions":2251},"NCT01925937","Atorvastatin\u002FCoenzymeQ10 in Congestive Heart Failure",[59],[2250],"Congestive Heart Failure",[461,2252],"Coenzyme Q10",{"intervention":1004,"totalTrials":16,"cells":2254},{"EARLY_PHASE1":2255,"PHASE1":2257,"PHASE2":2259,"PHASE3":2261,"PHASE4":2267,"NA":2269},{"trials":2256,"activeCount":66},[],{"trials":2258,"activeCount":66},[],{"trials":2260,"activeCount":66},[],{"trials":2262,"activeCount":66},[2263],{"nctId":997,"briefTitle":998,"status":161,"phases":2264,"primaryCompletion":227,"completion":227,"start":321,"enrollment":1000,"conditions":2265,"interventions":2266},[56,57],[1002],[986,1004],{"trials":2268,"activeCount":66},[],{"trials":2270,"activeCount":66},[2271,2280],{"nctId":2272,"briefTitle":2273,"status":196,"phases":2274,"primaryCompletion":2275,"start":347,"enrollment":2103,"conditions":2276,"interventions":2278},"NCT02327117","Low Dose Peri- Operative Intra Venous Teranexamic Acid Reduces Blood Loss After Total Knee Arthroplasty: A Double Blind Randomized Placebo Controlled Clinical Trial",[59],"2015-01",[2277],"Knee Arthroplasty, Total",[2279,1004],"Tranexamic Acid",{"nctId":2281,"briefTitle":2282,"status":196,"phases":2283,"primaryCompletion":2284,"completion":2285,"start":2286,"enrollment":1027,"conditions":2287,"interventions":2289},"NCT03634605","Effect of Tetracycline Pleurodesis on Prevention of Primary Spontaneous Pneumothorax Recurrence",[59],"2016-10-22","2016-11-10","2015-05-05",[2288],"Primary Spontaneous Pneumothorax",[2290,1004,2291],"Tetracycline Topical Ointment","Lidocaine 2% Injectable Solution",{"intervention":1548,"totalTrials":23,"cells":2293},{"EARLY_PHASE1":2294,"PHASE1":2296,"PHASE2":2298,"PHASE3":2304,"PHASE4":2306,"NA":2308},{"trials":2295,"activeCount":66},[],{"trials":2297,"activeCount":66},[],{"trials":2299,"activeCount":66},[2300],{"nctId":1537,"briefTitle":1538,"status":196,"phases":2301,"primaryCompletion":1540,"completion":1541,"start":1542,"enrollment":1543,"conditions":2302,"interventions":2303},[56],[1545,1546],[1528,1548,1549],{"trials":2305,"activeCount":66},[],{"trials":2307,"activeCount":66},[],{"trials":2309,"activeCount":66},[2310],{"nctId":2311,"briefTitle":2312,"status":161,"phases":2313,"primaryCompletion":2275,"completion":211,"start":347,"enrollment":399,"conditions":2314,"interventions":2316},"NCT02268019","Hemostasis During Hypospadias Surgery",[59],[2315],"Hypospadias Repair",[1548],{"intervention":2279,"totalTrials":62,"cells":2318},{"EARLY_PHASE1":2319,"PHASE1":2321,"PHASE2":2323,"PHASE3":2325,"PHASE4":2327,"NA":2329},{"trials":2320,"activeCount":66},[],{"trials":2322,"activeCount":66},[],{"trials":2324,"activeCount":66},[],{"trials":2326,"activeCount":66},[],{"trials":2328,"activeCount":66},[],{"trials":2330,"activeCount":66},[2331],{"nctId":2272,"briefTitle":2273,"status":196,"phases":2332,"primaryCompletion":2275,"start":347,"enrollment":2103,"conditions":2333,"interventions":2334},[59],[2277],[2279,1004],{"intervention":2336,"totalTrials":62,"cells":2337},"Budesonide",{"EARLY_PHASE1":2338,"PHASE1":2340,"PHASE2":2342,"PHASE3":2344,"PHASE4":2346,"NA":2348},{"trials":2339,"activeCount":66},[],{"trials":2341,"activeCount":66},[],{"trials":2343,"activeCount":66},[],{"trials":2345,"activeCount":66},[],{"trials":2347,"activeCount":66},[],{"trials":2349,"activeCount":66},[2350],{"nctId":2351,"briefTitle":2352,"status":161,"phases":2353,"primaryCompletion":2354,"start":322,"enrollment":399,"conditions":2355,"interventions":2357},"NCT01786070","Effect of Nebulized Budesonide on Preventing Postextubation Complications in Critically Patients",[59],"2014-03",[2356],"Respiratory Sounds",[2336],{"intervention":2252,"totalTrials":62,"cells":2359},{"EARLY_PHASE1":2360,"PHASE1":2362,"PHASE2":2364,"PHASE3":2366,"PHASE4":2368,"NA":2370},{"trials":2361,"activeCount":66},[],{"trials":2363,"activeCount":66},[],{"trials":2365,"activeCount":66},[],{"trials":2367,"activeCount":66},[],{"trials":2369,"activeCount":66},[],{"trials":2371,"activeCount":66},[2372],{"nctId":2246,"briefTitle":2247,"status":161,"phases":2373,"primaryCompletion":1118,"start":345,"enrollment":374,"conditions":2374,"interventions":2375},[59],[2250],[461,2252],{"intervention":2290,"totalTrials":62,"cells":2377},{"EARLY_PHASE1":2378,"PHASE1":2380,"PHASE2":2382,"PHASE3":2384,"PHASE4":2386,"NA":2388},{"trials":2379,"activeCount":66},[],{"trials":2381,"activeCount":66},[],{"trials":2383,"activeCount":66},[],{"trials":2385,"activeCount":66},[],{"trials":2387,"activeCount":66},[],{"trials":2389,"activeCount":66},[2390],{"nctId":2281,"briefTitle":2282,"status":196,"phases":2391,"primaryCompletion":2284,"completion":2285,"start":2286,"enrollment":1027,"conditions":2392,"interventions":2393},[59],[2288],[2290,1004,2291],{"intervention":2291,"totalTrials":62,"cells":2395},{"EARLY_PHASE1":2396,"PHASE1":2398,"PHASE2":2400,"PHASE3":2402,"PHASE4":2404,"NA":2406},{"trials":2397,"activeCount":66},[],{"trials":2399,"activeCount":66},[],{"trials":2401,"activeCount":66},[],{"trials":2403,"activeCount":66},[],{"trials":2405,"activeCount":66},[],{"trials":2407,"activeCount":66},[2408],{"nctId":2281,"briefTitle":2282,"status":196,"phases":2409,"primaryCompletion":2284,"completion":2285,"start":2286,"enrollment":1027,"conditions":2410,"interventions":2411},[59],[2288],[2290,1004,2291],{"intervention":2413,"totalTrials":62,"cells":2414},"selective serotonin reuptake inhibitor",{"EARLY_PHASE1":2415,"PHASE1":2417,"PHASE2":2419,"PHASE3":2421,"PHASE4":2423,"NA":2425},{"trials":2416,"activeCount":66},[],{"trials":2418,"activeCount":66},[],{"trials":2420,"activeCount":66},[],{"trials":2422,"activeCount":66},[],{"trials":2424,"activeCount":66},[],{"trials":2426,"activeCount":66},[2427],{"nctId":2428,"briefTitle":2429,"status":196,"phases":2430,"primaryCompletion":2431,"completion":2432,"start":1497,"enrollment":2103,"conditions":2433,"interventions":2434},"NCT02884596","Success of Inferior Alveolar Nerve Block in Women Taking Selective Serotonin Reuptake Inhibitors",[],"2016-02","2016-03",[18],[2413]]